ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...

Podrobná bibliografie
Hlavní autoři:	Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group
Médium:	Journal article
Vydáno:	Elsevier 2017

Podobné jednotky

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
Autor: Parish, S, a další
Vydáno: (2022)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Emily L. Sammons, a další
Vydáno: (2024-11-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Autor: Sarah Parish, a další
Vydáno: (2023-03-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
Autor: Sammons, E, a další
Vydáno: (2024)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
Autor: Sammons, E, a další
Vydáno: (2023)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
Autor: Sammons, E, a další
Vydáno: (2023)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
Autor: Emily Sammons, a další
Vydáno: (2023-10-01)

Effects of aspirin for primary prevention in persons with diabetes mellitus
Autor: Bowman, L, a další
Vydáno: (2018)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
Autor: Aung, T, a další
Vydáno: (2016)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Autor: Parish, S, a další
Vydáno: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Sammons, EL, a další
Vydáno: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Sammons, EL, a další
Vydáno: (2024)

Effects of omega−3 fatty acid supplements on arrhythmias
Autor: Parish, S, a další
Vydáno: (2020)

Aspirin for primary prevention of vascular disease in people with diabetes.
Autor: Haynes, R, a další
Vydáno: (2009)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
Autor: Petrucci, G, a další
Vydáno: (2024)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
Autor: Praveen Patel, a další
Vydáno: (2025-02-01)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
Autor: Mafham, MM, a další
Vydáno: (2019)

The ASCEND-Eye study: effect(s) of aspirin and omega-3 fatty acids on eye disease
Autor: Sammons, E
Vydáno: (2023)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Autor: Aung, T, a další
Vydáno: (2017)

Effects of n-3 fatty acid supplements in diabetes mellitus
Autor: Ascend Study Collaborative Group, a další
Vydáno: (2018)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Autor: Rocca, B, a další
Vydáno: (2020)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
Autor: Harper, C, a další
Vydáno: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
Autor: Harper, C, a další
Vydáno: (2021)

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
Autor: Andrea K Viecelli, a další
Vydáno: (2019-01-01)

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Autor: Keng, MJ, a další
Vydáno: (2021)

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
Autor: Prathyusha Rampally, a další
Vydáno: (2019-01-01)

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion
Autor: Filip Hromcik, a další
Vydáno: (2021-06-01)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Autor: Hartweg, J, a další
Vydáno: (2008)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Autor: Hartweg, J, a další
Vydáno: (2008)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
Autor: Eugene Han, a další
Vydáno: (2016-01-01)

Synergistic effects of omega-3 polyunsaturated fatty acids and aspirin in the clinical practice – a narrative review
Autor: Zajac-Grabiec Anna, a další
Vydáno: (2024-03-01)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
Autor: Leila Azadbakht, a další
Vydáno: (2011-01-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Autor: Price, H, a další
Vydáno: (2009)

Aspirin for primary prevention of cardiovascular disease in diabetes
Autor: Ying Xing, a další
Vydáno: (2019-07-01)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
Autor: Emberson, JR, a další
Vydáno: (2007)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Autor: Cull, C, a další
Vydáno: (2004)

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
Autor: Tajuddin N, a další
Vydáno: (2016-04-01)

Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients
Autor: Pasquale Mone, a další
Vydáno: (2022-03-01)

The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study
Autor: Ebrahim Shakiba, a další
Vydáno: (2024-11-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
Autor: Collins, R, a další
Vydáno: (1996)